The Importance of Access to
Early Phase Clinical Trials and Precision Therapies
Since 2006, Childhood Cancer Canada has been the primary charitable funding partner of clinical trials and childhood cancer research for C17, comprised of Canada's leading pediatric oncologists and hematologists.
We support their efforts to improve outcomes and the quality of life for children and adolescents with cancer and serious blood disorders in Canada. Part of this effort involves spreading awareness and providing education on the importance of Canadian children having access to early phase clinical trials and precision therapies.
Research is a lifeline for many of these kids and these are some of their stories.
This clinical trial’s success could mean a new standard of care, Abi’s mom called it smooth sailing. Access to a clinical trial means more energy to dance and sing like a rock star.
Ashton’s rare cancer wasn’t responding to treatment. A clinical trial created a new lifeline. Access to a clinical trial got this active kid back to playing the sports he loves.
Cancer treatment isn’t one-size-fits-all. A clinical trial fit Gabby just right. Access to a clinical trial means more energy to bake cakes with her sister.
When Marky was told he was out of options, a clinical trial saved the day. Access to a clinical trial gave this jokester his sense of humour back.
Naomi’s cancer was worrisome for her family; a clinical trial eased their concerns. Access to a clinical trial means more time for tea with her stuffed bears.
Owen’s cancer was difficult to treat, a clinical trial made it look easy. Access to a clinical trial means having the strength to play with his dog Aussie.